Cargando…
Palovarotene reduces heterotopic ossification in juvenile FOP mice but exhibits pronounced skeletal toxicity
Fibrodysplasia ossificans progressiva (FOP) is a rare genetic disorder characterized by debilitating heterotopic ossification (HO). The retinoic acid receptor gamma agonist, palovarotene, and antibody-mediated activin A blockade have entered human clinical trials, but how these therapeutic modalitie...
Autores principales: | Lees-Shepard, John B, Nicholas, Sarah-Anne E, Stoessel, Sean J, Devarakonda, Parvathi M, Schneider, Michael J, Yamamoto, Masakazu, Goldhamer, David J |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
eLife Sciences Publications, Ltd
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6143342/ https://www.ncbi.nlm.nih.gov/pubmed/30226468 http://dx.doi.org/10.7554/eLife.40814 |
Ejemplares similares
-
Response to comment on 'Palovarotene reduces heterotopic ossification in juvenile FOP mice but exhibits pronounced skeletal toxicity'
por: Goldhamer, David J, et al.
Publicado: (2019) -
Comment on 'Palovarotene reduces heterotopic ossification in juvenile FOP mice but exhibits pronounced skeletal toxicity'
por: Pacifici, Maurizio, et al.
Publicado: (2019) -
An anti-ACVR1 antibody exacerbates heterotopic ossification by fibro-adipogenic progenitors in fibrodysplasia ossificans progressiva mice
por: Lees-Shepard, John B., et al.
Publicado: (2022) -
Anti-ACVR1 antibodies exacerbate heterotopic ossification in fibrodysplasia ossificans progressiva (FOP) by activating FOP-mutant ACVR1
por: Aykul, Senem, et al.
Publicado: (2022) -
A Network Pharmacology Study: Reveal the Mechanisms of Palovarotene Against Heterotopic Ossification
por: Huang, Junchao, et al.
Publicado: (2022)